Matches in Wikidata for { <http://www.wikidata.org/entity/Q83794604> ?p ?o ?g. }
Showing items 1 to 33 of
33
with 100 items per page.
- Q83794604 description "clinical trial" @default.
- Q83794604 description "ensayu clínicu" @default.
- Q83794604 description "klinisch onderzoek" @default.
- Q83794604 description "клінічне випробування" @default.
- Q83794604 name "Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Patients" @default.
- Q83794604 name "Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Patients" @default.
- Q83794604 type Item @default.
- Q83794604 label "Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Patients" @default.
- Q83794604 label "Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Patients" @default.
- Q83794604 prefLabel "Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Patients" @default.
- Q83794604 prefLabel "Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Patients" @default.
- Q83794604 P1132 Q83794604-E05457C3-EBDC-4EF1-9CAF-4A9A2840DD4B @default.
- Q83794604 P1476 Q83794604-D4ACDB71-E184-467F-9709-0DCFA50046DD @default.
- Q83794604 P17 Q83794604-AC476CDD-6F49-4922-A21B-7D2919921D57 @default.
- Q83794604 P2899 Q83794604-A8D2B2C7-4916-40D7-8273-77D8C6892A98 @default.
- Q83794604 P3098 Q83794604-3952D900-50BE-483A-A25B-DCA582EC2F24 @default.
- Q83794604 P31 Q83794604-BAA23CB6-5A93-409B-AAE8-E64C8A1E79C3 @default.
- Q83794604 P4135 Q83794604-B62EEBED-BAE1-42B9-B341-FA614F220D06 @default.
- Q83794604 P580 Q83794604-08154289-BFAB-47AD-856A-20FC4CA5D710 @default.
- Q83794604 P582 Q83794604-84CE0C0B-6570-47F4-A29C-2315FD9C412F @default.
- Q83794604 P6099 Q83794604-E5CA9AA0-0CE9-45F2-868A-B87D7E14D876 @default.
- Q83794604 P8363 Q83794604-475173CB-5940-48F7-BC47-A22EA9323D3E @default.
- Q83794604 P1132 "+85" @default.
- Q83794604 P1476 "An Open-label Study With a Nonrandomized Single-dose Phase in Subjects With Suspected or Confirmed Aerobic Gram-negative Bacterial Infections Followed by a Randomized, Multiple-dose, Active-controlled Phase in Subjects With Suspected or Confirmed Complicated Urinary Tract Infection (cUTI), to Assess the Safety, Tolerability, and Pharmacokinetics of Cefiderocol in Hospitalized Pediatric Subjects 3 Months to < 18 Years of Age" @default.
- Q83794604 P17 Q30 @default.
- Q83794604 P2899 "+3" @default.
- Q83794604 P3098 "NCT04215991" @default.
- Q83794604 P31 Q30612 @default.
- Q83794604 P4135 "+17" @default.
- Q83794604 P580 "2020-01-20T00:00:00Z" @default.
- Q83794604 P582 "2023-03-15T00:00:00Z" @default.
- Q83794604 P6099 Q42824440 @default.
- Q83794604 P8363 Q78089383 @default.